EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹124 Cr | ₹132 Cr | ₹404 Cr | ₹310 Cr | ₹222 Cr |
What is the latest Capital Work in Progress ratio of EMCURE PHARMACEUTICALS ?
| Year | Capital Work in Progress |
|---|---|
| Mar2025 | ₹124 Cr |
| Mar2024 | ₹132 Cr |
| Mar2023 | ₹404 Cr |
| Mar2022 | ₹310 Cr |
| Mar2021 | ₹222 Cr |
How is Capital Work in Progress of EMCURE PHARMACEUTICALS Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2025 | ₹124 Cr | -6.26 | |
| Mar2024 | ₹132 Cr | -67.20 | |
| Mar2023 | ₹404 Cr | 30.25 | |
| Mar2022 | ₹310 Cr | 39.81 | |
| Mar2021 | ₹222 Cr | - | |
Compare Capital Work in Progress of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹29,355.8 Cr | -2.9% | 6.5% | 55.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -2.9% |
6.5% |
55.1% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses